ATE409707T1 - Chemotaktisches protein für granulozyten - Google Patents

Chemotaktisches protein für granulozyten

Info

Publication number
ATE409707T1
ATE409707T1 AT94901896T AT94901896T ATE409707T1 AT E409707 T1 ATE409707 T1 AT E409707T1 AT 94901896 T AT94901896 T AT 94901896T AT 94901896 T AT94901896 T AT 94901896T AT E409707 T1 ATE409707 T1 AT E409707T1
Authority
AT
Austria
Prior art keywords
pct
gcp
date
chemotactic protein
mammalian
Prior art date
Application number
AT94901896T
Other languages
English (en)
Inventor
Damme Jo Van
Paul Proost
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of ATE409707T1 publication Critical patent/ATE409707T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT94901896T 1992-11-27 1993-11-26 Chemotaktisches protein für granulozyten ATE409707T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98253992A 1992-11-27 1992-11-27

Publications (1)

Publication Number Publication Date
ATE409707T1 true ATE409707T1 (de) 2008-10-15

Family

ID=25529269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94901896T ATE409707T1 (de) 1992-11-27 1993-11-26 Chemotaktisches protein für granulozyten

Country Status (6)

Country Link
US (1) US5840524A (de)
EP (1) EP0804486B1 (de)
AT (1) ATE409707T1 (de)
AU (1) AU5628394A (de)
DE (1) DE69334242D1 (de)
WO (1) WO1994012537A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5877276A (en) * 1994-09-23 1999-03-02 The Board Of Regents Of The University Of Nebraska Polypeptide agonists for human interleukin-8
US6139832A (en) * 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
US6410268B1 (en) 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
WO1997035027A1 (en) * 1996-03-18 1997-09-25 Human Genome Sciences, Inc. Chemokine alpha 3
NZ332318A (en) 1996-03-19 2000-10-27 Human Genome Sciences Inc Chemokine alpha 2 and it's therapeutic and diagnostic use in treating illnesses
AU4266197A (en) * 1996-09-12 1998-04-02 Incyte Pharmaceuticals, Inc. Granulocyte chemotactic protein 2 variant
WO1998014581A1 (en) * 1996-10-02 1998-04-09 Schering Corporation Mammalian chemokines
WO1998014477A1 (en) * 1996-10-04 1998-04-09 Human Genome Sciences, Inc. THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH LEUKOCYTE ADHESION INHIBITOR-1 (LAI-1), AND CHEMOKINE BETA-11 (Ckβ-11)
US7393696B2 (en) 2001-09-28 2008-07-01 Aspenbio Pharma, Inc. Bovine pregnancy test
EP1312614A1 (de) * 2001-11-16 2003-05-21 GenOdyssee Polynukleotide und Polypeptide des GCP-2 Gens
EP1546716A4 (de) 2002-05-02 2007-04-11 Aspenbio Inc Schwangerschaftsnachweis
CA2533124C (en) * 2003-08-12 2014-01-28 Tigenix N.V. Use of cxcl6 chemokine in the prevention or repair of cartilage defects
NZ573657A (en) * 2006-05-16 2011-09-30 Univ Saskatchewan High-affinity peptide antagonists of elr-cxc chemokines
WO2010070394A1 (en) * 2008-12-17 2010-06-24 Universite Pierre Et Marie Curie-Paris Vi Modulators of the cx3cr1 receptor and therapeutic uses thereof
GB202214951D0 (en) * 2022-10-11 2022-11-23 Univ London Queen Mary CXC receptor ligands

Also Published As

Publication number Publication date
DE69334242D1 (de) 2008-11-13
WO1994012537A3 (en) 1994-07-21
WO1994012537A2 (en) 1994-06-09
EP0804486B1 (de) 2008-10-01
AU5628394A (en) 1994-06-22
US5840524A (en) 1998-11-24
EP0804486A2 (de) 1997-11-05

Similar Documents

Publication Publication Date Title
DE69334242D1 (de) Chemotaktisches protein für granulozyten
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DK0792367T3 (da) DNA-konstruktion, der koder YAP3-signalpeptidet
NL300153I1 (nl) Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
DK0760857T3 (da) Receptor for onkostatin M
EA200000311A1 (ru) Новый белок иммунной системы - кау
ATE172743T1 (de) Nachweis von kollagenabbau -i(in vivo)
FI904951A0 (fi) Vaevnadsplasminogenaktivatorderivat.
FI943512A0 (fi) Ihmisen seerumialbumiini, valmistus ja käyttö
BR9407512A (pt) Sequência de ácidos nucléicos vírus recombinante defectivo vetor notadamente virale composição farmaceutica e utilização de uma sequencia de ácidos nucléicos
Mattick et al. The architecture of the animal fatty acid synthetase. II. Separation of the core and thioesterase functions and determination of the NC orientation of the subunit.
Kulkarni et al. Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation
ITRM920457A1 (it) Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
BR9510067A (pt) Peptídio capaz de interagir com o domínio sh3 da proteína gap anticorpo ou fragmento de anticorpo dirigido contra um polipeptídeo sequência nucleotídica codificando para um polipeptídio ácido nucléico anti-sentido capaz de inibir ao menos parcialmente a produção de polipeptídeos sua utilização composição farmacêutica e utilização de um anticorpo ou fragmento de anticorpo
DK0486572T3 (da) Forbedringer i granulocyt-makrofag-kolonistimulerende faktorreceptor og derivater deraf
FI952094A0 (fi) Ihmisen serotoniinireseptoria (5-HT4B)koodaava DNA ja sen käyttö
ATE190318T1 (de) Pcna bindende substanz
ATE314474T1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
ES2135398T3 (es) Compuesto y composiciones de inhibicion de la resorcion osea.
DK0580672T3 (da) Syntetisk CDw52-(CAMPATH-1)-peptidantigen
Hensbergen et al. Processing of natural and recombinant CXCR3‐targeting chemokines and implications for biological activity
AU4582393A (en) Antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them
DE69431603D1 (de) Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins
Fahnestock et al. . beta.-NGF-endopeptidase: structure and activity of a kallikrein encoded by the gene mGK-22
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties